Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent ... - PR Newswire (press release) PDF Print
PR Newswire (press release)
Vascugel is a novel endothelial cell-based therapy that aims to regulate the body's healing response following surgical interventions to create vascular access which are necessary for ESRD patients undergoing hemodialysis. By promoting and enhancing

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.